Related Experiment Video

Updated: Jun 20, 2026

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization
07:42

An In vitro Model to Study Heterogeneity of Human Macrophage Differentiation and Polarization

Published on: June 12, 2013

Macrophage diversity and polarization in atherosclerosis: a question of balance

Alberto Mantovani1, Cecilia Garlanda, Massimo Locati

  • 1Istituto Clinico Humanitas IRCCS, via Manzoni 56, 20089 Rozzano, Italy. alberto.mantovani@humanitas.it

Arteriosclerosis, Thrombosis, and Vascular Biology
|August 22, 2009
PubMed

Insights

Mononuclear phagocytes, including diverse monocyte subsets and plaque-associated macrophages, drive atherosclerosis plaque development and complications. Maintaining a "macrophage balance" is crucial for managing this complex cardiovascular disease.

Area of Science:

  • Immunology
  • Cardiovascular Biology
  • Cellular Biology

Background:

  • Mononuclear phagocytes exhibit significant diversity and plasticity, influencing atherosclerotic plaque formation and progression.
  • Distinct monocyte subsets contribute differently to plaque infiltration and atherosclerosis complications.
  • Plaque-associated macrophages display polarized pro- and antiatherogenic functions based on environmental cues.

Purpose of the Study:

  • To elucidate the role of mononuclear phagocyte diversity and plasticity in atherosclerosis.
  • To understand how different monocyte subsets and macrophage polarization impact plaque evolution and complications.
  • To highlight the significance of macrophage balance in atherogenesis.

Main Methods:

  • Analysis of monocyte subset contributions to plaque infiltration.
  • Investigation of environmental signals modulating macrophage polarization.
  • Assessment of macrophage influence on lipid metabolism, inflammation, and plaque stability.

Main Results:

  • Identification of distinct monocyte subsets with differential roles in atherosclerosis.
  • Demonstration of polarized macrophage programs affecting lipid metabolism and inflammation.
  • Evidence of macrophage influence on atherosclerotic plaque stability and evolution.

Conclusions:

  • Macrophage balance is a critical determinant in the pathogenesis of atherosclerotic plaques.
  • Mononuclear phagocyte diversity and plasticity significantly impact atherosclerosis evolution and complications.
  • Targeting macrophage balance may offer therapeutic strategies for atherosclerosis.

Related Concept Videos

Inflammation01:38

Inflammation

Overview
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...